Global Competition

Showing 1891 articles
Business

Moonshot AI's Latest Model Claims Edge Over U.S. Rivals as China's Tech Giants Secure Critical Nvidia Chips

Alibaba-backed Moonshot AI has unveiled an upgraded flagship model, Kimi K2.5, asserting superiority in video generation and agentic capabilities against leading U.S. models. The development coincides with Beijing's approval for major tech firms, including Alibaba, to import advanced Nvidia H200 AI chips, signaling a dual-track strategy in the intensifying global AI race.

Business

XRP's 40% Plunge: A Buying Opportunity or a Value Trap?

XRP, the cryptocurrency designed for global payments, has seen its value tumble over 40% in the past year. While its long-term promise to reshape cross-border finance remains, investors now face a critical juncture: is this a chance to buy the dip, or a sign of deeper troubles ahead?

Business

U.S. Bets on Rare Earths Diversity with $1.6 Billion Rival Backing, MP Materials Navigates New Policy Landscape

The U.S. government's $1.6 billion commitment to USA Rare Earth signals a strategic pivot towards fostering competition in the critical minerals sector, reducing price supports and introducing new volatility. As policy shifts, industry leader MP Materials counters with record production and expanded magnet manufacturing, highlighting the intensifying race to secure a domestic supply chain for EVs and defense.

Business

AerCap Holdings: The Aviation Giant Flying Under the Radar

AerCap Holdings N.V., the world's largest aircraft lessor, is drawing renewed attention from value investors. Despite geopolitical headwinds and a cyclical reputation, its robust cash flows, industry dominance, and compelling valuation present a strong case for a rerating, as global travel demand outpaces constrained aircraft supply.

Business

Adtalem Bets Big on Buybacks: A Strategic Pivot in Healthcare Education?

Adtalem Global Education posts strong Q2 fiscal 2026 results, raising revenue to $503.39M and net income to $76.38M, while reaffirming full-year guidance. The company's new $750M share repurchase authorization signals a dual commitment to capital returns and strategic growth in its healthcare education portfolio, even as regulatory and enrollment challenges linger.